Cerebain Biotech Corp. Stock Price - CBBT

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cerebain Biotech Corp. (QB) CBBT OTC BB Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0001 -10.00% 0.0009 0.001 0.0008 0.0009 0.001 16:59:59
Bid Price Ask Price Spread Spread % News
0.0008 0.00 0.0003 27.27% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
39 20,936,122 $ 0.000931 $ 19,500 27,676,822 0.00055 - 0.14
Last Trade Time Type Quantity Stock Price Currency
16:17:50 average 349,199 $ 0.00097 USD

Cerebain Biotech Corp. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 348.23k 386.92M $ -2.94M - - 4.04M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Cerebain Biotech Corp. News

Loading Messages....

Latest CBBT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CBBT Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.00130.00140.00080.001127M-0.0004-30.77%
1 Month0.0010.00180.00080.001225M-0.0001-10.00%
3 Months0.00220.00270.000550.001329M-0.0013-59.09%
6 Months0.009870.010670.000550.001717M-0.00897-90.88%
1 Year0.12510.140.000550.003210M-0.1242-99.28%
3 Years0.91.10.000550.00355M-0.8991-99.90%
5 Years1.3530.000550.00413M-1.3491-99.93%

Cerebain Biotech Corp. Description

Cerebain Biotech Corp. was incorporated on December 18, 2007 under the laws of Nevada. The Company is a smaller reporting biomedical company and through its wholly owned subsidiary, Cerebain Operating, Inc., the Company's business revolves around the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The Company plans to produce products that will include both a medical device solution as well as a synthetic drug solution.

Your Recent History
Cerebain B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.